18 May 2013
Keywords: india, nppa, announces, drug, price, revisions, national
Article | 11 April 2005
India's National Pharmaceutical Pricing Authority has, based on a detailed cost price study from Novartis, GTBL and Lupin, revised the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 April 2005
17 May 2013
© 2013 thepharmaletter.com